April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO

182 views 34 slides Apr 14, 2024
Slide 1
Slide 1 of 34
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34

About This Presentation

April 2024 ONCOLOGY CARTOON


Slide Content

DR KANHU CHARAN PATRO M.D, D.N.B[RT], MBA, FICRO, FAROI, PDCR, CEPC www.slideshare.net/search/slideshow?searchfrom=header&q=oncology+cartoons www.facebook.com/oncologycartoons/photos_albums 97 th Volume/APRIL 2024 ONCOLOGY CRATOONS EDUCATIVE E-BOOK

RERT IN HEAD & NECK CANCER MANDIBULAR COCHLEAR DOSE 16 th MARCH 2024/ RERT Matthew C./IJROBP/2022

RERT IN HEAD & NECK CANCER TEMPORAL LOBE & BRACHIAL DOSE 17 th MARCH 2024/ RERT Matthew C./IJROBP/2022

GENETIC FACTORS DECIDING THE LOCAL TREATMENT IN BREAST CANCER-1 18 th MARCH 2024/ BREAST Bruce G. Haffty / JCO/ 2022

GENETIC FACTORS DECIDING THE LOCAL TREATMENT IN BREAST CANCER-2 Bruce G. Haffty / ASCO/2022 19 th MARCH 2024/ BREAST

Algorithm for approach to colorectal polyps Avanish Saklani /IJC/2024 20 th MARCH 2024/ RECTUM

Surveillance approach to colorectal polyps Avanish Saklani /IJC/2024 21 st MARCH 2024/ RECTUM

Surveillance approach after colorectal resection Avanish Saklani /IJC/2024 22 nd MARCH 2024/ RECTUM

Surveillance approach after NACTRT rectum Avanish Saklani /IJC/2024 23 rd MARCH 2024/ RECTUM

Emerging tracers in neuro‑oncology Ameya D. Puranik /IJC/2024 24 th MARCH 2024/ PET

Emerging tracers in neuroblastoma Ameya D. Puranik /IJC/2024 25 th MARCH 2024/ PET

Node Reporting and Data System 1.0 (Node-RADS) Fabian H. J. Elsholtz / Eur Radiol (2021) 26 th MARCH 2024/ RADIOLOGY

Target delineation workflow in CANCER ANAL CANAL DR KANHU CHARAN PATRO 27 th MARCH 2024/ TARGET -1cm

Target delineation workflow in CANCER RECTUM DR KANHU CHARAN PATRO 28 th MARCH 2024/ TARGET -1cm

Target delineation workflow in POST OP PROSTATE MICHALSKI/IJROBP/2010 29 th MARCH 2024/ TARGET

RADIATION DOSING IN PITUITARY ADENOMA ARRO CASE 30 th MARCH 2024/ BRAIN

DECIDING RADIATION THERAPY IN PITUITARY ADENOMA ARRO CASE 31 st MARCH 2024/ BRAIN

DECIDING SYSTEMIC THERAPY IN PITUITARY TUMORS ARRO CASE 1 st APRIL 2024/ BRAIN

PITUITARY TUMORS SUBTYPES AND CLINICAL PRESENTATIONS ARRO CASE 2 nd APRIL 2024/ BRAIN

ROLE OF ADJUVANT RADIOTHERAPY IN POST OP PROSTATE ARRO CASE 3 rd APRIL 2024/ PROSTATE

DIFFERENT TYPES OF GLIOBLASTOMA AND OUTCOME ARRO CASE 4 th APRIL 2024/ BRAIN

RADILOGICAL PICTURE OF HEMANGIOPERICYTOMA RAGAV GUPTA/CUREUS/2017 5 th APRIL 2024/ BRAIN The magnetic resonance imaging (MRI) with contrast (A) sagittal (B) axial, and (C) coronal views depict a large contrast-enhancing mass arising from the olfactory groove, D: the MRI T2 weighted image demonstrates corkscrew type flow voids (white arrow), which are consistent with a highly vascular neoplasm.

NF1 VS NF2 ARRO CASE 6 th APRIL 2024/ BRAIN

COMPARISON OF APBI GUIDELINES IN BREAST CANCER OFFICIAL STATEMENT OF ASBRS 7 th APRIL 2024/ BREAST

Adj.RT options for early-stage invasive breast cancer or DCIS Simona F/PRO/2024 8 th APRIL 2024/ BREAST

EBRT APBI GUIDELINES FOR GCP AND TDF PARAMETERS Simona F/PRO/2024 9 th APRIL 2024/ BREAST

BRACHY APBI GUIDELINES FOR GCP AND TDF PARAMETERS Simona F/PRO/2024 10 th APRIL 2024/ BREAST

ASTRO APBI GUIDELINES IN BREAST CANCER ARRO CASE 11 th APRIL 2024/ BREAST

SUMMARY OF PMRT TRIALS IN POST MRM CASES ARRO CASE 12 th APRIL 2024/ BREAST

BOKHMAN SUBTYPES OF ENDOMETRIAL CANCER P. Morice /SEMANTIC SHOLAR/2015 13 th APRIL 2024/ ENDOMETRIUM

CHLAMYDIA PSITTACI AND OORBITAL MALT LYMPHOMA DANIELLE A. CUNNINGHAM, MD/TWITTER 14 th APRIL 2024/ LYMPHOMA Chlamydia psittaci identified in ~25% of orbital MALT on meta-analysis. Chlamydia psittaci association with orbital MALT lymphoma varies by region: – Common in Italy, Austria, Germany, and parts of the US 100 mg Doxycycline BID for 3 weeks – Response assessment 3-4 weeks after treatment Radiation therapy

APRIL IS NATIONAL ORAL CANCER AWARENESS MONTH GOOGLE 15 th APRIL 2024/ PUBLIC Gutkha Goodkha
Tags